» Articles » PMID: 15678072

Vasopressin to Attenuate Pulmonary Hypertension and Improve Systemic Blood Pressure After Correction of Obstructed Total Anomalous Pulmonary Venous Return

Overview
Date 2005 Jan 29
PMID 15678072
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Use of vasopressin in persistent pulmonary hypertension of the newborn: A case series.

Joshi S, Quinones Cardona V, Menkiti O SAGE Open Med Case Rep. 2022; 10:2050313X221102289.

PMID: 35693924 PMC: 9178974. DOI: 10.1177/2050313X221102289.


Pulmonary Hypertension in Intensive Care Units: An Updated Review.

Nowroozpoor A, Malekmohammad M, Seyyedi S, Hashemian S Tanaffos. 2020; 18(3):180-207.

PMID: 32411259 PMC: 7210574.


Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia in a rat model of pulmonary hypertension.

Sugawara Y, Mizuno Y, Oku S, Goto T Br J Anaesth. 2019; 122(4):437-447.

PMID: 30857600 PMC: 6435915. DOI: 10.1016/j.bja.2019.01.014.


Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension.

Hoeper M, Benza R, Corris P, de Perrot M, Fadel E, Keogh A Eur Respir J. 2018; 53(1).

PMID: 30545979 PMC: 6351385. DOI: 10.1183/13993003.01906-2018.


Arginine Vasopressin and Copeptin in Perinatology.

Evers K, Wellmann S Front Pediatr. 2016; 4:75.

PMID: 27532032 PMC: 4969663. DOI: 10.3389/fped.2016.00075.